AI assistant
Sending…
Biocon Ltd. — Interim / Quarterly Report 2020
Nov 21, 2019
61176_rns_2019-11-21_a5fac072-d569-4c1a-8959-23331d2ff23a.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
==> picture [147 x 29] intentionally omitted <==
==> picture [455 x 93] intentionally omitted <==
==> picture [97 x 44] intentionally omitted <==
==> picture [78 x 77] intentionally omitted <==
| Nameofrelatedparties | Natureofrelationship |
|---|---|
| Keymanagement personnelKiranMazumdar-ShawArun ChandavarkarSiddharthMittalMayank VermaRussellWallsDaniel M BradburyJeremy MLevinMary HarneyVijay K KuchrooM DamodaranBobby K ParikhJohn ShawRaviMazumdarJoint VenturesNeoBioconFZLLCOther related partiesBiocon Foundationlmmuneel Therapeutics Private LimitedMazumdar Shaw Medical FoundationGlentec International LimitedCatherine RosenbergJeevesNarayana Hrudayalaya LimitedP K Associates | Chairperson&Managing DirectorJoint Managing Director&CEOPresident- Finance and Chief Financial OfficerCompany Secretary (w.e.f July 25, 2019)Independent director (upto July,25 2019)Independent directorIndependent directorIndependent directorIndependent directorIndependent directorIndependent directorNon-executive directorNon-executive directorJoint-ventureTrust in which key management personnel are the BoardofTrusteesEnterprise in which a directoroftheCompanyisa shareholderTrust in which key management personnel are the BoardofTrusteesEnterprise owned by key management personnelRelativeofa directorEnterpriseinwhich relativetoa directorofthe CompanyisproprietorEnterprise in which a directoroftheCompanyisa memberofboardofdirectorsProprietary firmofrelativeofdirector |
| Particulars | Transactions_I_Balances | Half year endedSeptember 30,2019 |
|---|---|---|
| Key management personnelJointVentureOther related parties | Salary and perquisites [refer note (a)&(b) below]Sitting fees and commissionOutstandingasattheperiod end:-Trade andotherpayablesPurchaseofgoodsSalespromotion expensesExpensesincurred on behalfoftherelated partyOutstandingasat the period end:-Trade and other receivables-Trade and other payablesSaleofgoodsSaleofservicesHealth services availedExpensestowards Scientific and Research servicesCSRExpenditureOther expensesOutstandingasat the period end:-Trade and other receivables-Trade and otherpayables | 63184108122•-24443•-2123212313 |
==> picture [79 x 80] intentionally omitted <==
More from Biocon Ltd.
Investor Presentation
2026
Jun 1
Investor Presentation
2026
Jun 1
Proxy Solicitation & Information Statement
2026
May 30
Regulatory Filings
2026
May 30
Proxy Solicitation & Information Statement
2026
May 29
Proxy Solicitation & Information Statement
2026
May 29
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22